Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...
The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...
Due to increased demand, some doses of Wegovy (semaglutide) are currently in short supply. Depending on the strength a doctor prescribes, you may find it difficult to get this medication.
Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...
The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback